🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Erin L. Winstanley

West Virginia University

ORCID: 0000-0003-3571-0259

Also affiliated with University of Pittsburgh

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.104Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Substance use as subtext to health narratives: Identifying opportunities for improving care from community member perspectives

Patient Education and Counseling(2024)10.1016/j.pec.2024.108384
Top 78%
0.104DataRank
Top 78%1 citations

J. Deanna Wilson, Young Ji Lee, Natasha Norman, Erin L. Winstanley, Kathleen M. McTigue +1 more

Papers

Driven by 12 papers — median percentile 22. Top paper: “Study Protocol for Pain Self-Management and Patient-Oriented Buprenorphine Dosing for Pain and Retention in Office-Based Opioid Treatment: A Hybrid Type 1, 2 × 2 Factorial Randomized Controlled Trial”.

Study Protocol for Pain Self-Management and Patient-Oriented Buprenorphine Dosing for Pain and Retention in Office-Based Opioid Treatment: A Hybrid Type 1, 2 × 2 Factorial Randomized Controlled Trial

Substance Use &amp Addiction Journal(2024)10.1177/29767342241261562
N/A
0.241DataRank · unranked
4 citations

Karlyn A. Edwards, Erin L. Winstanley, Rachel L. Bachrach, Hailey W. Bulls, Janel Hanmer +7 more

Introduction to the special series: using evidence to enhance health services for individuals using drugs in rural communities

Addiction Science & Clinical Practice(2024)10.1186/s13722-024-00489-z
N/A
0.165DataRank · unranked
2 citations

Sterling McPherson, P. Todd Korthuis, Erin L. Winstanley

Substance use as subtext to health narratives: Identifying opportunities for improving care from community member perspectives

Patient Education and Counseling(2024)10.1016/j.pec.2024.108384
Top 78%
0.104DataRank
Top 78%1 citations

J. Deanna Wilson, Young Ji Lee, Natasha Norman, Erin L. Winstanley, Kathleen M. McTigue +1 more

Feasibility and acceptability of safety screening among patients receiving addiction treatment

Journal of Substance Abuse Treatment(2020)10.1016/j.jsat.2020.108092
N/A
0DataRank · unranked
3 citations

Ian R. H. Rockett, Gordon S. Smith, Traci LeMasters, Virginia Scott, Kimberly M. Kelly +2 more

Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review

International Journal of Drug Policy(2022)10.1016/j.drugpo.2022.103931
N/A
0DataRank · unranked
23 citations

Marissa Justen, Amanda M. Bunting, Melissa Funaro, Erin L. Winstanley, Paul J. Joudrey +1 more

A pilot study investigating cognitive impairment associated with opioid overdose

Drug and Alcohol Dependence(2023)10.1016/j.drugalcdep.2023.109865
N/A
0DataRank · unranked
8 citations

Erin L. Winstanley, Felipe Castillo, Rachel Luba, Jennifer L. Marton, Daniel M. Alschuler +3 more

Using digital technologies in clinical trials: Current and future applications

Contemporary Clinical Trials(2020)10.1016/j.cct.2020.106219
N/A
0DataRank · unranked
101 citations

Lisa A. Marsch, Erin L. Winstanley, Meg Brunner, Aimee Campbell, Carmen La Rosa

Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study

Substance Abuse Treatment Prevention and Policy(2024)10.1186/s13011-023-00587-2
N/A
0DataRank · unranked
1 citations

Zheng Dai, Caroline P. Groth, Brian Hendricks, Erin L. Winstanley, Marie A. Abate +2 more

Morbidity, mortality, and health outcomes following emergency department visits for fentanyl-related overdoses: A retrospective cohort study

Drug and Alcohol Dependence Reports(2025)10.1016/j.dadr.2025.100405
N/A
0DataRank · unranked
1 citations

Samantha Nash, Baylee Farmer, Zebulun Mallow, Liv E. Miller, E. Ashley Six-Workman +3 more

10-year retention of a comprehensive treatment model of buprenorphine for opioid use disorder

Journal of Addictive Diseases(2024)10.1080/10550887.2024.2315366
N/A
0DataRank · unranked
5 citations

Megan Cavrak, Hannah Riley Bowles, Yongjia Deng, Sijin Wen, Si Gao +4 more

High prevalence of co-occurring substance use in individuals with opioid use disorder

Addictive Behaviors(2020)10.1016/j.addbeh.2020.106752
N/A
0DataRank · unranked
61 citations

Erin L. Winstanley, Laura R. Lander, James H. Berry, Patrick Marshalek, Marc W. Haut +7 more

Something to despair: Gender differences in adverse childhood experiences among rural patients

Journal of Substance Abuse Treatment(2020)10.1016/j.jsat.2020.108056
N/A
0DataRank · unranked
41 citations

James J. Mahoney, Laura R. Lander, James H. Berry, Patrick Marshalek, Wanhong Zheng +2 more